Those type of tumors are homogeneous vs heterogenous. DCVAX theoretically fixes this challenge.
Fully personalized to the tumor itself.
Many solid tumors are hetero among patients and among different tumors or even within regions of the tumor itself.
Start at minute 5.
"if you think about the heterogeneity of the disease... no one should be surprised that these previous immunotherapies didn't work" -paraphrasing but..